More articles from Osteoporosis Update
- Raloxifene: A new choice for treating and preventing osteoporosis
The pros and cons of estrogen replacement therapy, bisphosphonates, and raloxifene, the first of a new class of selective estrogen receptor modulators.
- Diagnosis and treatment of glucocorticoid-induced osteoporosis
Nearly everyone loses bone mass when they take corticosteroids long-term. Physicians should take proactive steps to mitigate the problem.